Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and interleukin-8

erlotinib hydrochloride has been researched along with interleukin-8 in 8 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(interleukin-8)		Trials
(interleukin-8)		Recent Studies (post-2010) (interleukin-8)
4,3537863,03323,5231,1679,990

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, K; Kimura, T; Kira, Y; Kudoh, S; Matsuura, K; Mitsuoka, S; Nagata, M; Nakai, T; Oka, T; Suzumura, T; Umekawa, K; Yoshimura, N1
Chen, C; Cretoiu, SM; Shi, L; Wang, B; Wang, L; Wang, Q; Wang, X1
Boeck, S; Brockmöller, J; Hasheminasab, SM; Heinemann, V; Hichert, V; Kächele, V; Rüdiger, S; Scholl, C; Schumann, C; Seufferlein, T; Steffens, M; Stingl, JC; Tzvetkov, MV1
David, JM; Dominguez, C; Fernando, RI; Hamilton, DH; McCampbell, KK; Palena, C1
Addeo, R; Alaia, C; Boccellino, M; Caraglia, M; Grimaldi, A; Kast, RE; Nicoletti, GF; Quagliuolo, L1
Dominguez, C; Palena, C; Tsang, KY1
Li, C; Li, Q; Liu, J; Liu, Y; Peng, L; Wang, H; Wu, J; Xia, L; Xia, Y1
Chao, YH; Chen, PJ; Hsiao, YP; Kang, YT; Ko, JL; Lue, KH; Pan, HH; Sheu, JN1

Reviews

1 review(s) available for erlotinib hydrochloride and interleukin-8

ArticleYear
The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.
    Current medical research and opinion, 2016, Volume: 32, Issue:11

    Topics: Antineoplastic Agents; Dapsone; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Interleukin-8

2016

Other Studies

7 other study(ies) available for erlotinib hydrochloride and interleukin-8

ArticleYear
Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.
    BMC research notes, 2013, Apr-08, Volume: 6

    Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemokine CCL5; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-10; Interleukin-8; Lung Neoplasms; Male; Middle Aged; Mutation; Quinazolines; Treatment Outcome

2013
Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells.
    Journal of translational medicine, 2014, Mar-16, Volume: 12

    Topics: Apoptosis; Betacellulin; Cell Count; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cycloheximide; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-8; Lipopolysaccharides; Lung Neoplasms; Models, Biological; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Quinazolines; Receptor Protein-Tyrosine Kinases; Tumor Necrosis Factor-alpha

2014
High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors.
    Pharmacogenomics, 2015, Volume: 16, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Frequency; Heterozygote; High-Throughput Nucleotide Sequencing; Humans; Inflammation; Interleukin-8; Introns; Male; Middle Aged; Polymorphism, Single Nucleotide; Signal Transduction; Survival Analysis

2015
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.
    Oncotarget, 2016, Jul-05, Volume: 7, Issue:27

    Topics: A549 Cells; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Interleukin-8; Lung Neoplasms; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Phenotype; Quinazolines; Signal Transduction; Up-Regulation

2016
Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.
    Cell death & disease, 2016, 09-29, Volume: 7, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Erlotinib Hydrochloride; Humans; Interleukin-8; Lung Neoplasms; Mutation; Phenotype; Receptors, Death Domain; Signal Transduction; Time Factors

2016
Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model.
    Cell death & disease, 2018, 07-23, Volume: 9, Issue:8

    Topics: Animals; Cell Proliferation; Chemokine CCL5; Cytokines; Disease Models, Animal; Erlotinib Hydrochloride; Humans; Interleukin-6; Interleukin-8; Keratin-17; Keratinocytes; Mice; Mice, Inbred BALB C; Mice, Knockout; Psoriasis; RNA Interference; RNA, Small Interfering; Skin; TWEAK Receptor; Up-Regulation

2018
Epithelial growth factor receptor tyrosine kinase inhibitors alleviate house dust mite allergen Der p2-induced IL-6 and IL-8.
    Environmental toxicology, 2019, Volume: 34, Issue:4

    Topics: Acrylamides; Aniline Compounds; Animals; Antigens, Dermatophagoides; Arthropod Proteins; Asthma; Cell Line; Dermatophagoides pteronyssinus; Dose-Response Relationship, Drug; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Humans; Interleukin-6; Interleukin-8; Respiratory Mucosa; Signal Transduction

2019